Targeting the ROS-ferroptosis axis: A clinical perspective on oxidative stress management in systemic lupus erythematosus

2025/10/04 by Xiaoyan Xu, Wenfeng Gao, Lei Pang +3
Medicine · Biochemistry, Genetics and Molecular Biology · Immunology and Microbiology · #Ferroptosis and cancer prognosis #Cancer-related molecular mechanisms research #Atherosclerosis and Cardiovascular Diseases

paper · doi:10.1016/j.amjms.2025.10.001

Citations

• N ‐acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: A randomized, double‐blind, placebo‐controlled trial